Literature DB >> 23233576

Making a diagnosis of VWD.

Brian R Branchford1, Jorge Di Paola.   

Abstract

A clear understanding of the molecular basis of VWD can guide the choice and interpretation of appropriate diagnostic tests. This review briefly describes the lifecycle and molecular interactions of VWF and how they lead to the current clinical classification. It also includes a brief discussion of the differential diagnosis and general workup of mucocutaneous bleeding, a review of the various VWD subtypes, and pertinent laboratory assays for each, including genetic tests. Finally, common testing pitfalls and diagnostic dilemmas are covered, including the challenge created by the overlap of borderline low VWF levels and mild bleeding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233576      PMCID: PMC5873588          DOI: 10.1182/asheducation-2012.1.161

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  27 in total

1.  Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.

Authors:  V H Flood; J C Gill; P A Christopherson; J S Wren; K D Friedman; S L Haberichter; R G Hoffmann; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

3.  Hermansky-Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakistani kindreds.

Authors:  C Harrison; K Khair; B Baxter; I Russell-Eggitt; I Hann; R Liesner
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

4.  Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.

Authors:  M Cattaneo; A Lecchi; B Agati; R Lombardi; M L Zighetti
Journal:  Thromb Res       Date:  1999-11-01       Impact factor: 3.944

Review 5.  How I treat the acquired von Willebrand syndrome.

Authors:  Andreas Tiede; Jacob H Rand; Ulrich Budde; Arnold Ganser; Augusto B Federici
Journal:  Blood       Date:  2011-05-03       Impact factor: 22.113

6.  Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.

Authors:  E J Favaloro; R Bonar; K Chapman; M Meiring; D Funk Adcock
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

Review 7.  Low von Willebrand factor: sometimes a risk factor and sometimes a disease.

Authors:  J Evan Sadler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

8.  Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.

Authors:  T Quiroga; M Goycoolea; B Muñoz; M Morales; E Aranda; O Panes; J Pereira; D Mezzano
Journal:  J Thromb Haemost       Date:  2004-06       Impact factor: 5.824

9.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287

10.  Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.

Authors:  Rohit Cariappa; Timothy R Wilhite; Curtis A Parvin; Lori Luchtman-Jones
Journal:  J Pediatr Hematol Oncol       Date:  2003-06       Impact factor: 1.289

View more
  3 in total

1.  Simplagrin, a platelet aggregation inhibitor from Simulium nigrimanum salivary glands specifically binds to the Von Willebrand factor receptor in collagen and inhibits carotid thrombus formation in vivo.

Authors:  Andrezza C Chagas; Peter McPhie; Hong San; David Narum; Karine Reiter; Fuyuki Tokomasu; Fabio A Brayner; Luiz C Alves; José M C Ribeiro; Eric Calvo
Journal:  PLoS Negl Trop Dis       Date:  2014-06-12

2.  Report on von Willebrand Disease in Malaysia.

Authors:  Mercy Halleluyah Periayah; Ahmad Sukari Halim; Arman Zaharil Mat Saad; Nik Soriani Yaacob; Faraizah Abdul Karim
Journal:  Open Access Maced J Med Sci       Date:  2016-02-29

Review 3.  Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors.

Authors:  Michael A Mazzeffi; Khang Lee; Bradley Taylor; Kenichi A Tanaka
Journal:  Korean J Anesthesiol       Date:  2017-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.